Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy
This year’s Seed Awards will support projects ranging from the discovery sciences and patient care to sustainability and diversity, equity, and inclusion
Seth Shipman, PhD, left, and Santiago C. Lopez in discussion in the laboratory. The two led the lab’s recent work pioneering an improved method for genome editing across the kingdoms of life.
Recent findings from the laboratory of Seth Shipman, PhD, show that a type of bacterial DNA known as a retron can be harnessed to dramatically improve genome editing.
A human cell (green) infected with SARS-CoV-2 virus particles (purple). Research from QBI has identified how the Alpha variant of the virus evades the human immune system.
Findings from QBI point to a host of viral proteins that enable SARS-CoV-2 variants to evade the immune system.
A child sits on a bed surrounded by a bed net intended to prevent mosquito bites that could transmit malaria, Kenya. A new drug regimen developed at UCSF offers children improved protection against the disease.
Study shows that monthly doses of two common anti-malarial drugs for the first few years of life can provide 95 percent protection against the disease.
A birds-eye depiction of the findings from the Quantitative Biosciences Institute’s recent work on cancer. Each node represents a protein system and darker-colored nodes are more likely to be involved in cancer.
Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head
